EOS-CJCIPAM
CJC-1295 + Ipamorelin
Synergistic GHRH + GH secretagogue blend for growth hormone research
For Research Use Only. This product is intended solely for laboratory and research purposes. It is not intended for human consumption or for use in the diagnosis, treatment, cure, or prevention of any disease. By purchasing, you confirm you are a qualified researcher and agree to use this product only for lawful research purposes.
Description
This blend combines CJC-1295 (no DAC), a synthetic analogue of growth hormone-releasing hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue. The combination creates synergistic growth hormone releasing effects through complementary receptor pathways — CJC-1295 through GHRH receptors and Ipamorelin through ghrelin receptors. Combined administration shows amplified GH release compared to either peptide alone while maintaining a selective release profile with minimal effects on cortisol and prolactin.